Guardion Health Sciences, Inc. Made Big Gain
Guardion Health Sciences, Inc. (GHSI:NASDAQ) shot up at $0.37, representing a gain of 42.4%. On Tue 22 Dec 20, GHSI:NASDAQ hit a New 2-Week High of $0.26. The stock got featured on our News Catalysts scanner on Thu 10 Dec 20 at 08:10 PM in the 'INVESTOR UPDATE' category. From Tue 08 Dec 20, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Tue 01 Dec 20 at $0.32 with a volume of 16M+, and its share price has been moving sideways in recent weeks.
About Guardion Health Sciences, Inc. (GHSI:NASDAQ)
Guardion Health Sciences Inc is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product. The company's Lumega-Z, is a micronized lipid-base nutritional formulation designed to restore and maintain the condition of a depleted macular pigment. It has also developed GlaucoCetin, the first regulated vision-specific Medical Food designed to support and protect the mitochondrial function of optic nerve cells in patients with glaucoma.
Top 10 Gainers:
- Ocugen, Inc. (OCGN:NASDAQ), 222.9%
- Jaguar Health, Inc. (JAGX:NASDAQ), 170.34%
- XL Group Ltd (XL:NYSE), 86.02%
- Foresight Autonomous Holdings Ltd. (FRSX:NASDAQ), 78.02%
- Acasti Pharma Inc. (ACST:NASDAQ), 72%
- Senseonics Holdings, Inc. (SENS:NYSEMKT), 50.47%
- SCPS (SCPS:NASDAQ), 47.71%
- EOSE (EOSE:NASDAQ), 44.56%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 42.35%
- Bionano Genomics, Inc. (BNGO:NASDAQ), 40.4%